| Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension R De Franchis Journal of hepatology 63 (3), 743-752, 2015 | 3877 | 2015 |
| Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases G Garcia‐Tsao, JG Abraldes, A Berzigotti, J Bosch Hepatology 65 (1), 310-335, 2017 | 2265 | 2017 |
| Baveno VII–renewing consensus in portal hypertension R De Franchis, J Bosch, G Garcia-Tsao, T Reiberger, C Ripoll, ... Journal of hepatology 76 (4), 959-974, 2022 | 1897 | 2022 |
| EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version) CF Dietrich, J Bamber, A Berzigotti, S Bota, V Cantisani, L Castera, ... Ultraschall in der Medizin-European Journal of Ultrasound 38 (04), e16-e47, 2017 | 1156 | 2017 |
| EASL Clinical Practice Guidelines on nutrition in chronic liver disease M Merli, A Berzigotti, S Zelber-Sagi, S Dasarathy, S Montagnese, ... Journal of hepatology 70 (1), 172-193, 2019 | 907 | 2019 |
| EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update CPG Panel, A Berzigotti, E Tsochatzis, J Boursier, L Castera, N Cazzagon, ... Journal of hepatology 75 (3), 659-689, 2021 | 865 | 2021 |
| The clinical use of HVPG measurements in chronic liver disease J Bosch, JG Abraldes, A Berzigotti, JC García-Pagan Nature reviews Gastroenterology & hepatology 6 (10), 573-582, 2009 | 807 | 2009 |
| Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis A Berzigotti, S Seijo, U Arena, JG Abraldes, F Vizzutti, JC García–Pagán, ... Gastroenterology 144 (1), 102-111. e1, 2013 | 627 | 2013 |
| Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations G Ferraioli, VWS Wong, L Castera, A Berzigotti, I Sporea, CF Dietrich, ... Ultrasound in medicine & biology 44 (12), 2419-2440, 2018 | 525 | 2018 |
| Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2020–WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS CF Dietrich, CP Nolsøe, RG Barr, A Berzigotti, PN Burns, V Cantisani, ... Ultraschall in der Medizin-European Journal of Ultrasound 41 (05), 562-585, 2020 | 523 | 2020 |
| The management of portal hypertension: rational basis, available treatments and future options J Bosch, A Berzigotti, JC Garcia-Pagan, JG Abraldes Journal of hepatology 48, S68-S92, 2008 | 515 | 2008 |
| A MELD-based model to determine risk of mortality among patients with acute variceal bleeding E Reverter, P Tandon, S Augustin, F Turon, S Casu, R Bastiampillai, ... Gastroenterology 146 (2), 412-419. e3, 2014 | 433 | 2014 |
| Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta‐analysis A Berzigotti, M Reig, JG Abraldes, J Bosch, J Bruix Hepatology 61 (2), 526-536, 2015 | 402 | 2015 |
| Assessing portal hypertension in liver diseases A Berzigotti, S Seijo, E Reverter, J Bosch Expert review of gastroenterology & hepatology 7 (2), 141-155, 2013 | 402 | 2013 |
| Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study JG Abraldes, C Bureau, H Stefanescu, S Augustin, M Ney, H Blasco, ... Hepatology 64 (6), 2173-2184, 2016 | 372 | 2016 |
| Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis C Zafra, JG Abraldes, J Turnes, A Berzigotti, M Fernández, ... Gastroenterology 126 (3), 749-755, 2004 | 351 | 2004 |
| Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis A Berzigotti, G Garcia‐Tsao, J Bosch, ND Grace, AK Burroughs, ... Hepatology 54 (2), 555-561, 2011 | 348 | 2011 |
| Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis JG Abraldes, C Villanueva, C Aracil, J Turnes, M Hernandez-Guerra, ... Gastroenterology 150 (5), 1160-1170. e3, 2016 | 341 | 2016 |
| Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension D Franchis, JG Abraldes, J Bajaj, A Berzigotti, J Bosch, AK Burroughs, ... Journal of hepatology 63 (3), 743-752, 2015 | 325 | 2015 |
| Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study A Berzigotti, A Albillos, C Villanueva, J Genescá, A Ardevol, S Augustín, ... Hepatology 65 (4), 1293-1305, 2017 | 315 | 2017 |
Jaime Bosch (or Jaume Bosch)Professor of Medicine. University of Barcerlona-IDIBAPS, and Guest Professor, Bern University.clinic.ub.es의 이메일 확인됨
